We use essential cookies and third-party cookies for content.

The National Times - Asian markets fluctuate after healthy week of tech gains

Asian markets fluctuate after healthy week of tech gains

ECONOMY 27.02.2026
Asian markets fluctuate after healthy week of tech gains
Asian markets fluctuate after healthy week of tech gains / Photo: © AFP

Markets stuttered Friday as traders took their foot off the pedal at the end of a healthy week in Asia, where tech firms rallied on a reassessment of AI investments.

Change text size:

After surging for the past two years on a rush into all things linked to artificial intelligence, Wall Street's Magnificent Seven tech titans have been slow out of the blocks this year amid concerns about extended valuations and profitability.

Worries about the impact of new tools that many warn pose a risk to a range of companies were compounded by a report on Sunday that signified parts of the global economy that could be at risk from the new gadgets, including credit card and food delivery firms.

That uncertainty has seen a shift from "downstream" companies that run apps and software to "upstream" firms such as chipmakers, many of which are based in Asia.

That was highlighted this week by another Wall Street sell-off, despite Nvidia reporting quarterly profits more than doubled, projecting more strong growth for the coming period.

Analysts said the losses showed firms needed to far exceed even elevated forecasts, making it even harder to please investors who have been piling into tech in recent years.

"Market expectations were already very elevated and part of the positive results had been priced in," said City Index's Julian Pineda.

"There are also concerns related to stretched valuations and Nvidia’s dependence on capital spending by large technology companies investing in AI infrastructure.

"If the pace of AI investment moderates due to cost optimisation efforts, it could indirectly affect Nvidia's growth outlook."

Most of Wall Street fell, with the Nasdaq shedding more than one percent.

Asia was mixed, with the Supreme Court's decision last Friday to slap down many of US President Donald Trump's tariffs seen largely benefiting regional economies.

Hong Kong, Singapore and Wellington edged up, while Sydney and Shanghai shifted between gains and losses.

But Seoul sank more than one percent, having chalked up gains of around 8.5 percent this week thanks to a surge in market heavyweights Samsung and SK hynix.

Tokyo, Manila and Jakarta also fell.

The yen extended a minor recovery against the dollar after a top Bank of Japan board member again urged officials to continue hiking interest rates.

However, the case for a pause was boosted by data showing Tokyo's inflation -- seen as a barometer for the country -- cooled last month.

The currency came under pressure this week after Prime Minister Sanae Takaichi nominated two academics to the BoJ board who are considered policy doves, days after reports said she had told its boss Kazuo Ueda of her concern about tightening further.

Oil prices slipped after mediators said Iran and the United States made "significant progress" in nuclear talks Thursday as they look to avert a war in the crude-rich Middle East. The two sides agreed to further discussions next week in Austria.

The Oman-mediated negotiations follow repeated threats from Trump to strike Tehran, with the US president last Thursday giving it 15 days to reach a deal.

- Key figures at around 0230 GMT -

Tokyo - Nikkei 225: DOWN 0.4 percent at 58,528.09 (break)

Hong Kong - Hang Seng Index: UP 0.2 percent at 26,427.58

Shanghai - Composite: FLAT at 4,146.82

Dollar/yen: DOWN at 155.85 yen from 156.11 yen on Thursday

Euro/dollar: DOWN at $1.1796 from $1.1799

Pound/dollar: DOWN at $1.3484 from $1.3489

Euro/pound: UP at 87.49 pence from 87.47 pence

West Texas Intermediate: DOWN 0.3 percent at $65.02 per barrel

Brent North Sea Crude: DOWN 0.3 percent at $70.54 per barrel

New York - Dow: UP less than 0.1 percent at 49,499.20 (close)

London - FTSE 100: UP 0.4 percent at 10,846.70 (close)

Q.Marshall--TNT

Featured

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

CapTLX, the securities trading and investment platform operated by CHAINLION TECH LTD, today announced the continued expansion of its technology infrastructure for qualified investors and institutional market participants seeking structured access to U.S. equity and private capital markets.

Change text size: